Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts
- PMID: 23420232
- PMCID: PMC3638215
- DOI: 10.7326/0003-4819-158-4-201302190-00003
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts
Abstract
Chinese translation
Background: Hepatitis C virus (HCV) infections occur worldwide and either spontaneously resolve or persist and markedly increase the person's lifetime risk for cirrhosis and hepatocellular carcinoma. Although HCV persistence occurs more often in persons of African ancestry and persons with genetic variants near interleukin-28B (IL-28B), the genetic basis is not well-understood.
Objective: To evaluate the host genetic basis for spontaneous resolution of HCV infection.
Design: 2-stage, genome-wide association study.
Setting: 13 international multicenter study sites.
Patients: 919 persons with serum HCV antibodies but no HCV RNA (spontaneous resolution) and 1482 persons with serum HCV antibodies and HCV RNA (persistence).
Measurements: Frequencies of 792 721 single nucleotide polymorphisms (SNPs).
Results: Differences in allele frequencies between persons with spontaneous resolution and persistence were identified on chromosomes 19q13.13 and 6p21.32. On chromosome 19, allele frequency differences localized near IL-28B and included rs12979860 (overall per-allele OR, 0.45; P = 2.17 × 10-30) and 10 additional SNPs spanning 55 000 base pairs. On chromosome 6, allele frequency differences localized near genes for HLA class II and included rs4273729 (overall per-allele OR, 0.59; P = 1.71 × 10-16) near DQB1*03:01 and an additional 116 SNPs spanning 1 090 000 base pairs. The associations in chromosomes 19 and 6 were independent and additive and explain an estimated 14.9% (95% CI, 8.5% to 22.6%) and 15.8% (CI, 4.4% to 31.0%) of the variation in HCV resolution in persons of European and African ancestry, respectively. Replication of the chromosome 6 SNP, rs4272729, in an additional 745 persons confirmed the findings (P = 0.015).
Limitation: Epigenetic effects were not studied.
Conclusion: IL-28B and HLA class II are independently associated with spontaneous resolution of HCV infection, and SNPs marking IL-28B and DQB1*03:01 may explain approximately 15% of spontaneous resolution of HCV infection.
Figures
Similar articles
-
Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.Gastroenterology. 2019 Apr;156(5):1496-1507.e7. doi: 10.1053/j.gastro.2018.12.014. Epub 2018 Dec 26. Gastroenterology. 2019. PMID: 30593799 Free PMC article.
-
A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.Gastroenterology. 2011 Jul;141(1):320-5, 325.e1-2. doi: 10.1053/j.gastro.2011.04.005. Epub 2011 Apr 14. Gastroenterology. 2011. PMID: 21600205 Free PMC article.
-
Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1.Am J Hum Genet. 2022 Feb 3;109(2):299-310. doi: 10.1016/j.ajhg.2022.01.001. Epub 2022 Jan 31. Am J Hum Genet. 2022. PMID: 35090584 Free PMC article.
-
The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C.Clin Dev Immunol. 2012;2012:849373. doi: 10.1155/2012/849373. Epub 2012 Aug 27. Clin Dev Immunol. 2012. PMID: 22966241 Free PMC article. Review.
-
Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19.Exp Biol Med (Maywood). 2023 May;248(9):787-797. doi: 10.1177/15353702231181343. Epub 2023 Jul 15. Exp Biol Med (Maywood). 2023. PMID: 37452704 Free PMC article. Review.
Cited by
-
IMGT/RobustpMHC: robust training for class-I MHC peptide binding prediction.Brief Bioinform. 2024 Sep 23;25(6):bbae552. doi: 10.1093/bib/bbae552. Brief Bioinform. 2024. PMID: 39504482 Free PMC article.
-
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C.Clin Exp Med. 2024 Aug 8;24(1):184. doi: 10.1007/s10238-024-01432-x. Clin Exp Med. 2024. PMID: 39117877 Free PMC article.
-
Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles.J Virol. 2024 Aug 20;98(8):e0028124. doi: 10.1128/jvi.00281-24. Epub 2024 Jul 24. J Virol. 2024. PMID: 39046263 Clinical Trial.
-
Frequency of the Main Human Leukocyte Antigen A, B, DR, and DQ Loci Known to Be Associated with the Clearance or Persistence of Hepatitis C Virus Infection in a Healthy Population from the Southern Region of Morocco: A Preliminary Study.Diseases. 2024 May 16;12(5):106. doi: 10.3390/diseases12050106. Diseases. 2024. PMID: 38785761 Free PMC article.
-
A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection and allergy.Am J Hum Genet. 2024 Feb 1;111(2):295-308. doi: 10.1016/j.ajhg.2023.12.013. Epub 2024 Jan 16. Am J Hum Genet. 2024. PMID: 38232728 Free PMC article.
References
-
- Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 1998;282:103–7. - PubMed
-
- Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology. 1999;29:908–14. - PubMed
-
- Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. New England Journal of Medicine. 1999;340:1228–33. - PubMed
-
- Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450–456. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UO1-AI-34994/AI/NIAID NIH HHS/United States
- UO1-AI-34989/AI/NIAID NIH HHS/United States
- AI082630/AI/NIAID NIH HHS/United States
- R01HL076902/HL/NHLBI NIH HHS/United States
- U19AI088791/AI/NIAID NIH HHS/United States
- UO1-AI-35041/AI/NIAID NIH HHS/United States
- UO1-AI-35004/AI/NIAID NIH HHS/United States
- UO1-AI-34993/AI/NIAID NIH HHS/United States
- U19 AI066345/AI/NIAID NIH HHS/United States
- UL1-RR025005/RR/NCRR NIH HHS/United States
- DA12568/DA/NIDA NIH HHS/United States
- UL1-RR024996/RR/NCRR NIH HHS/United States
- UO1-AI-42590/AI/NIAID NIH HHS/United States
- UO1-AI-31834/AI/NIAID NIH HHS/United States
- U01 DA036297/DA/NIDA NIH HHS/United States
- UO1-HD-32632/HD/NICHD NIH HHS/United States
- R01 DA033541/DA/NIDA NIH HHS/United States
- UO1-AI-35042/AI/NIAID NIH HHS/United States
- R01-DA16159/DA/NIDA NIH HHS/United States
- P30 DK026743/DK/NIDDK NIH HHS/United States
- R01 DA013324/DA/NIDA NIH HHS/United States
- UO1-AI-35040/AI/NIAID NIH HHS/United States
- DA04334/DA/NIDA NIH HHS/United States
- U19 AI082630/AI/NIAID NIH HHS/United States
- HHSN261200800001C/CA/NCI NIH HHS/United States
- R01-DA21550/DA/NIDA NIH HHS/United States
- R01013324/PHS HHS/United States
- UO1-AI-35039/AI/NIAID NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- UL1 TR000457/TR/NCATS NIH HHS/United States
- HHSN261200800001E/CA/NCI NIH HHS/United States
- DA033541/DA/NIDA NIH HHS/United States
- UO1-AI-35043/AI/NIAID NIH HHS/United States
- G1001738/MRC_/Medical Research Council/United Kingdom
- U19 AI088791/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials